Physician profile
Scott E Thomas
NPI 1063664894
$4,473.79
in general payments reported to CMS, 2019-2025
7 companies · $31.57 in 2025
The $31.57 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.24 · 2020: $700 · 2021: $256 · 2022: $1,198 · 2023: $2,132 · 2024: $71.40 · 2025: $31.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,173 · Consulting Fee: $700 · Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,172.50 |
| Consulting Fee | $700.00 |
| Food and Beverage | $362.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pajunk Medical Systems, LP | $2,620.04 | 2019-2023 | E-Cath Plus Acc. Tsui |
| Heron Therapeutics, INC. | $1,337.93 | 2021-2023 | Zynrelef |
| Avanos Medical | $345.81 | 2023-2025 | On-Q* Pump and Accessories, On-Q Pump and Accessories |
| Pacira Pharmaceuticals Incorporated | $71.34 | 2021 | |
| Baudax Bio INC. | $61.98 | 2022 | |
| Smith+Nephew, INC. | $19.55 | 2021 | |
| Edwards Lifesciences Corporation | $17.14 | 2024 | Hemosphere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.